Distribution increase

Business

Dolby Laboratories Surpasses Expectations in Q1 2026, Driven by Automotive and Streaming Growth

Dolby Laboratories (NYSE: DLB) kicked off fiscal 2026 with robust first-quarter results, exceeding its own revenue and earnings forecasts. The audio-visual technology leader credits strong deal timing and highlighted significant momentum in automotive, television, and mobile partnerships, including expanded ties with Qualcomm and major social media platforms.

Jan 30, 2026

Business

Deckers Outdoor Soars on HOKA Momentum, UGG Resilience; Raises Full-Year Outlook

Fueled by record-breaking demand for its HOKA and UGG brands, Deckers Outdoor posts a robust Q3, beating expectations. The company credits disciplined full-price selling and strategic marketplace management for driving growth across all regions, leading to an upward revision of its fiscal 2026 guidance.

Jan 30, 2026

Business

VinFast Accelerates: Global EV Deliveries More Than Double in 2025, Led by Southeast Asian Surge

Vietnamese automaker VinFast reports a 102% surge in global vehicle deliveries for 2025, with Indonesia emerging as its top overseas market as the company expands its manufacturing footprint across Asia.

Feb 5, 2026

Business

Hyundai-Kia Shatters January Sales Record in U.S. Market as Hybrid Demand Soars, EVs Stumble

Hyundai Motor Group posts a record U.S. sales month for January, fueled by a 66% surge in hybrid vehicle deliveries. The milestone comes despite headwinds for electric models following IRA tax credit changes.

Feb 5, 2026

Business

Evercore Posts Record Quarter, Boosts Shareholder Returns: Is the Rally Sustainable?

Investment bank Evercore capped a record year with strong Q4 results, announcing a dividend hike and completing a major share buyback. While the numbers underscore operational strength, analysts debate whether the stock's premium valuation adequately prices in cyclical risks.

Feb 5, 2026

Business

Sotera Health's Valuation Puzzle: Undervalued by DCF, Overpriced on P/E Amid Pharma Sector Scrutiny

Sotera Health's stock presents a valuation conundrum, with discounted cash flow analysis suggesting a 37% upside while its sky-high P/E ratio signals overvaluation. As investors reassess biotech and pharmaceutical services firms, the debate intensifies around SHC's true worth.

Feb 5, 2026

Business

The Branch is Not Dead: How Data and Analytics Are Redefining the Future of Physical Banking

Despite a decade of closures, major banks are reinvesting in branches—not as transaction centers, but as data-driven advisory hubs. Advanced analytics is key to personalizing service, improving profitability, and serving community needs in an increasingly digital world.

Feb 5, 2026

Business

Phillips 66 Caps Record 2025 with Strong Earnings, Lays Out Ambitious Cost and Growth Targets Through 2027

Phillips 66 reported robust fourth-quarter and full-year 2025 results, driven by refining efficiency and midstream growth. CEO Mark Lashier outlined a strategic path focused on cost reduction, portfolio optimization, and disciplined capital returns to shareholders.

Feb 5, 2026

Business

Performance Food Group Navigates Economic Headwinds, Posts Resilient Q2 Amidst Industry Slowdown

Despite facing a challenging macroeconomic climate marked by reduced restaurant visits and a government shutdown, Performance Food Group (PFGC) reported fiscal Q2 2026 results in line with its guidance, showcasing growth in sales and profitability while prioritizing debt reduction.

Feb 5, 2026

World

Amid Escalating Strikes, U.S.-Mediated Ukraine Peace Talks Enter Second Day in Abu Dhabi

As Russia intensifies winter attacks on Ukraine's energy infrastructure, negotiators from both sides, with U.S. envoys present, continue high-stakes talks seeking a path to end the nearly four-year war, despite a reported surge in civilian casualties.

Feb 5, 2026

Business

Atmos Energy Shareholders Greenlight Full Slate of Proposals, Backing Board and Executive Pay

Shareholders of Atmos Energy (NYSE: ATO) have delivered a strong vote of confidence, approving all eight proposals at the annual meeting. The sweeping approvals include the election of the full board, ratification of the auditor, and key governance amendments, signaling smooth sailing for the natural gas utility's leadership and strategic direction.

Feb 5, 2026

Business

Regional Management Caps 2025 with Strong Growth, Eyes Auto Loans and Expansion for 2026

Consumer finance provider Regional Management (NYSE: RM) reported robust fourth-quarter and full-year 2025 results, fueled by portfolio expansion and improved credit metrics. The company's leadership outlined an ambitious 2026 roadmap centered on branch network growth, a strategic push into auto-secured lending, and sustained tech investment.

Feb 5, 2026

Business

The New York Times Posts Strong Digital Growth in 2025, Eyes Video Expansion

The New York Times Company reported robust digital subscriber and revenue gains for 2025, driven by its subscription-first strategy. While navigating a challenging media landscape, executives outlined ambitious plans to scale video content and leverage AI, even as costs rise.

Feb 5, 2026

Business

Prudential Faces $350M Hit from Japan Sales Scandal, Voluntarily Halts New Business for 90 Days

Prudential Financial's solid 2025 results were overshadowed by a misconduct scandal in its Japan unit, prompting a voluntary 90-day sales halt and a projected $300-$350 million earnings impact for 2026. CEO Andy Sullivan vowed to restore trust as the insurer navigates regulatory scrutiny and revamps its sales practices.

Feb 5, 2026

Business

Siemens Healthineers Navigates China Headwinds as Imaging and Therapy Units Drive Solid Q1

Siemens Healthineers reported a resilient start to fiscal 2026, with strong performance in its imaging and precision therapy divisions offsetting a significant downturn in its diagnostics business in China, prompting a strategic reassessment of its operations in the key Asian market.

Feb 5, 2026

Business

Novartis Beats Profit Target Ahead of Schedule, Charts Course Through Generic Headwinds

The Swiss pharma giant reported robust 2025 results, hitting a key profitability goal early. While facing near-term pressure from U.S. generic competition, CEO Vas Narasimhan outlined a strategy anchored by a portfolio of growth brands and a promising late-stage pipeline.

Feb 5, 2026

Business

Pfizer Bets Big on Monthly Shots in Bid to Challenge Obesity Drug Dominance

With a $7 billion acquisition and a pipeline focused on convenience, Pfizer is mounting a strategic challenge to Eli Lilly and Novo Nordisk's weight-loss drug stronghold, though commercial impact remains years away.

Feb 5, 2026

Business

Powering the AI Boom: Two Utility Giants Poised for Growth

As surging data center demand electrifies the traditionally steady utility sector, NextEra Energy and Dominion Energy emerge as key infrastructure players with compelling total return prospects.

Feb 5, 2026

Business

Rural Wedding Venues Sound Alarm Over Labour's Tax Reforms

Industry leaders warn that soaring business rates and a lack of government support threaten the viability of countryside weddings, potentially pricing out couples and stifling a rural economic success story.

Feb 5, 2026

Business

Social Security's 2027 COLA Forecast: A Modest Rise That May Fall Short for Seniors

An early projection suggests a smaller cost-of-living adjustment for 2027, renewing concerns about benefits keeping pace with retirees' actual expenses.

Feb 5, 2026